Cargando…

Review of the use of pretest probability for molecular testing in non-small cell lung cancer and overview of new mutations that may affect clinical practice

This article considers the use of pretest probability in non-small cell lung cancer (NSCLC) and how its use in EGFR testing has helped establish clinical guidelines on selecting patients for EGFR testing. With an ever-increasing number of molecular abnormalities being identified and often limited ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Petra, Leighl, Natasha B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455881/
https://www.ncbi.nlm.nih.gov/pubmed/28607579
http://dx.doi.org/10.1177/1758834017704329